🔗 Permalink

Assignee profile:

STEMRIM INC.

City:

Osaka

Country:

Japan

Published Applications:

Last publication date:

2026-03-05

Patent Grants:

Last grant date:

2025-09-30

Top Inventors for applications by STEMRIM INC.

These are the the leading inventors for applications assigned to STEMRIM INC.:

Takehiko Yamazaki 9 Osaka, Japan
Katsuto Tamai 9 Osaka, Japan
Takashi SHIMBO 4 Osaka, Japan
Takehiko YAMAZAKI 3 Toyonaka-shi, Osaka, Japan

Katsuto TAMAI 3 Suita-shi, Osaka, Japan
Mayumi Endo 3 Osaka, Japan
Kana Naito 2 Osaka, Japan
Natsumi Hamabuchi 2 Osaka, Japan

Shigeru Sakurai 2 Osaka, Japan
Yasufumi Kaneda 2 Osaka, Japan
Tsutomu Kanezaki 2 Osaka, Japan
Takenao CHINO 2 Osaka, Japan

Yukiko Noguchi 2 Osaka, Japan
Takashi SHIMBO 2 Suita-shi, Osaka, Japan
Eiji Sasaki 1 Suita, Japan
Eiji SASAKI 1 Suita-shi, Osaka, Japan

Takahiro AOTO 1 Suita-shi, Osaka, Japan
Koichi YOKOTA 1 Sakai-shi, Osaka, Japan
Takashi Shimbo 1 Suita, Japan
Takashi KIDO 1 Osaka, Japan

Katsuto Tamai 1 Suita, Japan
Eiji SASAKI 1 Osaka, Japan
Shigeru Miyagawa 1 Osaka, Japan
Takehiko YAMAZAKI 1 Ibaraki-shi, Osaka, Japan

Takasumi GOTO 1 Osaka, Japan
Takehiko Yamazaki 1 Toyonaka, Japan
Katsuto TAMAI 1 Toyonaka-shi, Osaka, Japan
Tomoki TAMAKOSHI 1 Suita-shi, Osaka, Japan

Kotaro Saga 1 Osaka, Japan
Yoshiki Sawa 1 Osaka, Japan
Yasushi KIKUCHI 1 Suita-shi, Osaka, Japan

Recent patent applications by STEMRIM INC.

STEMRIM INC. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-05

US20260062677A1

Chemistry; metallurgy

ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME

#2 | 2024-02-15

US20240050481A1

Human necessities

COMPOSITION FOR USE IN TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA

#3 | 2022-12-01 ✅ Patent 12,428,458 granted on 2025-09-30

US20220380420A1

Chemistry; metallurgy

Therapeutic Agent for Psoriasis

#4 | 2022-08-25

US20220265787A1

Human necessities

COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF MESENCHYMAL STEM CELLS

#5 | 2021-11-11 ✅ Patent 12,304,933 granted on 2025-05-20

US20210347839A1

Chemistry; metallurgy

Disease treatment drug based on mesenchymal-stem-cell mobilization

#6 | 2020-12-10 ✅ Patent 11,298,403 granted on 2022-04-12

US20200384074A1

Human necessities

Therapeutic agent for inflammatory bowel disease

#7 | 2020-09-17 ✅ Patent 12,421,498 granted on 2025-09-23

US20200291359A1

Chemistry; metallurgy

ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME

#8 | 2019-11-28

US20190358307A1

Human necessities

THERAPEUTIC AGENT FOR CEREBRAL INFARCTION

#9 | 2019-11-14 ✅ Patent 11,826,401 granted on 2023-11-28

US20190343924A1

Human necessities

Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure

#10 | 2018-03-15 ✅ Patent 10,550,165 granted on 2020-02-04

US20180072785A1

Chemistry; metallurgy

Peptide for inducing regeneration of tissue and use thereof

#11 | 2018-03-01 ✅ Patent 11,197,895 granted on 2021-12-14

US20180055886A1

Human necessities

Method for collecting functional cells in vivo with high efficiency

#12 | 2014-07-24 ✅ Patent 10,160,792 granted on 2018-12-25

US20140206619A1

Chemistry; metallurgy

Peptide for inducing regeneration of tissue and use thereof

#13 | 2012-10-04 ✅ Patent 11,191,786 granted on 2021-12-07

US20120251510A1

Human necessities

Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood

Also check out StemRIM Inc.'s (Osaka, Japan) applicant profile with 9 patent applications submitted.

AssigneeID:

163058 ⎘